| Literature DB >> 22611386 |
Lars Prag Antonsen1, Knut Arvid Kirkebøen.
Abstract
Background. Goal-directed fluid therapy reduces morbidity and mortality in various clinical settings. Respiratory variations in photoplethysmography are proposed as a noninvasive alternative to predict fluid responsiveness during mechanical ventilation. This paper aims to critically evaluate current data on the ability of photoplethysmography to predict fluid responsiveness. Method. Primary searches were performed in PubMed, Medline, and Embase on November 10, 2011. Results. 14 papers evaluating photoplethysmography and fluid responsiveness were found. Nine studies calculated areas under the receiver operating characteristic curves for ΔPOP (>0.85 in four, 0.75-0.85 in one, and <0.75 in four studies) and seven for PVI (values ranging from 0.54 to 0.98). Correlations between ΔPOP/PVI and ΔPP/other dynamic variables vary substantially. Conclusion. Although photoplethysmography is a promising technique, predictive values and correlations with other hemodynamic variables indicating fluid responsiveness vary substantially. Presently, it is not documented that photoplethysmography is adequately valid and reliable to be included in clinical practice for evaluation of fluid responsiveness.Entities:
Year: 2012 PMID: 22611386 PMCID: PMC3353145 DOI: 10.1155/2012/617380
Source DB: PubMed Journal: Anesthesiol Res Pract ISSN: 1687-6962
Papers in which ΔPOP and/or PVI have been evaluated and fluid challenges performed.
| Author, Ref. | Fluid challenge | CO/CI/SVI measurement | Responder | ROC | Threshold value | Sens/spec |
|---|---|---|---|---|---|---|
| Solus-Biguenet et al. [ | 250 mL colloid | Thermodilution | SVI: 10% | 0.81 | PPVfina: 14% | No data |
| 0.68 | ΔPOP: 9.5% | No data | ||||
| 0.79 | PPVart: 12.5% | No data | ||||
| Natalini et al. [ | 500 mL HES 6% | Thermodilution | CI: 15% | 0.72 | ΔPOP: 15% | 56/86 (PPV/NPV) |
| 0.74 | ΔPP: 15% | 55/100 (PPV/NPV) | ||||
| Cannesson et al. [ | 500 mL HES 6% | Thermodilution | CI: 15% | 0.847 | ΔPOP: 13% | 93/90 |
| 0.847 | ΔPP: 11% | 80/90 | ||||
| Feissel et al. [ | 8 mL/kg HES 6% | Echo-Doppler | CI: 15% | 0.94 | ΔPP: 12% | 100/70 |
| 0.94 | ΔPOP: 14% | 94/80 | ||||
| Wyffels et al. [ | 500 mL HES 6% | Intermittent thermodilution | CO: 15% | 0.94 | PPV: 11.3% | 95/91.7 |
| by pulm. artery catheter | 0.89 | ΔPOP: 11.3% | 90/83.3 | |||
| Cannesson et al. [ | 500 mL HES 6% | Thermodilution | CI: 15% | 0.94 | ΔPP: 12.5% | 87/89 |
| 0.94 | ΔPOP: 12% | 87/89 | ||||
| 0.93 | PVI: 14% | 81/100 | ||||
| Westphal et al. [ | 500–1000 mL NaCl | Not measured | ΔPP > 13% | 0.95 | ΔPOP: 11% | 91/100 |
| Zimmermann et al. [ | 7 mL/kg HES 6% | FloTrac | SVI: 15% | 0.97 | PVI: 9.5 % | 93/100 |
| Loupec et al. [ | 500 mL HES | Echocardiography | CO: 15% | 0.88 | PVI: 17% | 95/91 |
| or PLR if ΔPP < 13% | ||||||
| Desgranges et al. [ | 500 mL HES | Thermodilution | CI: 15% | 0.91 | PVIforehead : 15% | 89/78 |
| 0.88 | PVIear: 16% | 74/74 | ||||
| 0.84 | PVIfinger : 12% | 74/67 | ||||
| 0.84 | PPV > 11% | 74/89 | ||||
| PVIforehead : 15% | 89/100 | |||||
| and PIforehead : 1.37 | ||||||
| Renner et al. [ | HES 10 mL kg−1 | Transoesophageal echocardiography | SVI: 15% | 0.79 | PVI > 13% | 84/64 |
| De Souza Neto et al. [ | Saline, 20 mL/kg | Transthoracic echography | AVTI: 15% | 0.51 | 0–6 yr: ΔPOP | No data |
| (aortic velocity-time integral) | 0.63 | 0–6 yr: PVI | No data | |||
| 0.71 | 0–6 yr: ΔPP | No data | ||||
| 0.52 | 0–6 yr: PPV | No data | ||||
| 0.57 | 6–14 yr: ΔPOP | No data | ||||
| 0.54 | 6–14 yr: PVI | No data | ||||
| 0.60 | 6–14 yr: ΔPP | No data | ||||
| 0.60 | 6–14 yr: PPV | No data | ||||
| Hoiseth et al. [ | 250 mL colloid | Esophageal doppler | SV ≥ 15% | 0.67 | ΔPP: 8.8% | 82/67 |
| 0.72 | ΔPOP: 11.4% | 86/67 | ||||
| Hood and wilson [ | 500 mL colloid | Esophageal doppler | SV ≥ 10% | 0.96 | PVIfinger (baseline) 10% | 86/100 |
| 0.98 | PVIearlobe (baseline) 9.5% | 95/100 | ||||
| 0.71 | PVIfinger (during surgery) 10% | 65/67 | ||||
| 0.54 | PVIearlobe (during surgery) |
ΔPOP: pulse oximetry plethysmography; ΔPP: pulse pressure; PVI: Pleth variability index; CI: cardiac index; SV: stroke volume; SVI: stroke volume index; SVV: stroke volume variation; CO: cardiac output; PPVfina: pulse pressure variation obtained with Finapres; PPVart: pulse pressure variation obtained with intraarterial equipment; PPV/NPV: positive predictive value/negative predictive value.
Papers in which correlations between ΔPOP, PVI, and ΔPP have been investigated.
| Author, Ref. | Relation | Correlation | Pulse oximeter/monitor |
|---|---|---|---|
| Cannesson et al. [ | ΔPOP-ΔPP |
| M1190A, Philips, Suresnes, France |
| Natalini et al. [ | ΔPOP-ΔPP |
| Datex-Engstrom CS/3 Critical Care Monitor, Instrumentarium, Helsinki, Finland |
| Cannesson et al. [ | ΔPOP-ΔPP |
| Oxymax Tyco Healthcare Group LP, Pleasanton, CA, USA |
| Intellivue MP70, Philips Medical Systems, Suresnes, France | |||
| Landsverk et al. [ | ΔPOP-ΔPP |
| OxiMax 451N5, Nellcor, Boulder, CO, USA |
| Cannesson et al. [ | ΔPOP-PVI |
| LNOP Adt, Masimo Corp., Irvine, CA, USA |
| PVI-ΔPP |
| Oxymax, Tyco Healthcare Group LP, Pleasanton, CA, USA | |
| ΔPOP-ΔPP |
| Intellivue MP70, Philips Medical Systems, Suresnes, France | |
| Pizov et al. [ | ΔPOP-ΔPP |
| Datex-Ohmeda AS-3, Datex, Helsinki, Finland |
| Desebbe et al. [ | PVI VT = 6-PVI VT = 10 | 9%–12%, | LNOP Adt, Masimo Corp., Irvine, CA, USA |
| PVIPEEP- PVInon - PEEP | (Significant change) | ||
| Biais et al. [ | PVI-ΔPP |
| LNOP Adt, Masimo Corp., Irvine, CA, USA |
| PVINE(+)-ΔPP |
| Masimo Radical 7 monitor, Masimo SET, Masimo Corp., Irvine, CA, USA | |
| PVINE(−)-ΔPP |
| ||
| Solus-Biguenet et al. [ | No data | ||
| Natalini et al. [ | Datex-Engstrom CS/3 Critical Care Monitor, Instrumentarium, Helsinki, Finland | ||
| Cannesson et al. [ | ΔPOP-ΔPP |
| Oxymax Tyco Healthcare Group LP, Pleasanton, CA, USA |
| Intellivue MP70, Philips Medical Systems, Suresnes, France | |||
| Feissel et al. [ | ΔPOP-ΔPP |
| SpO2/Pleth, M3150A technology, Philips Medical Systems, Andover, MA, USA |
| Wyffels et al. [ | Monitor Hewlett Packard M1166A model G65 | ||
| Cannesson et al. [ | ΔPOP-PVI |
| LNOP Adt, Masimo Corp., Irvine, CA, USA, with Masimo Radical 7, 7.0.3.3 |
| Oxymax, Tyco Healthcare Group LP, Pleasanton, CA, USA | |||
| Westphal et al. [ | ΔPOP-ΔPP |
| S/5, Datex-Ohmeda, Helsinki, Finland |
| Zimmermann et al. [ | LNCS, Masimo Corp., Irvine, CA, USA, Masimo Radical-7 monitor, 7.0.3.3 | ||
| Loupec et al. [ | PVIbaseline -ΔPPbaseline |
| LNCS Adtx, Masimo corp., Irvine, CA, USA |
| Desgranges et al. [ | LNOP Adt, Masimo Corp., Irvine, CA, USA | ||
| LNOP TC-I, Masimo Corp., Irvine, CA, USA | |||
| LNOP TF-I, Masimo Corp., Irvine, CA, USA | |||
| Masimo Radical 7, Masimo SET, Masimo Corp., version 7.1.1.5 | |||
| Renner et al. [ | Masimo Rainbow SET, Masimo Corp., Radical 7, V7.6.2.2 | ||
| De Souza et al. [ | ΔPOP-PVI |
| Oxymax |
| ΔPOP-ΔPP |
| LNOP, Masimo Corp., Irvine, CA, USA | |
| PVI-PPV |
| ||
| Hoiseth et al. [ | ΔPOP-ΔPP |
| OxiMax 451N5, Nellcor, Boulder, CO, USA |
| Hood and wilson [ | Masimo Rainbow SET, Masimo Corp., Irvine, CA, USA |
ΔPOP: pulse oximetry plethysmography; ΔPP: pulse pressure; PVI: Pleth variability index; PEEP: positive end expiratory pressure; NE: norepinephrine; VT: tidal volume.
General characteristics.
| Author, Ref. | Year |
| Patient category | Ventilation | Site of meas. | Reg. period | Vasoact. |
|---|---|---|---|---|---|---|---|
| Cannesson et al. [ | 2005 | 22 | ICU | Mech. vent. 6–10 mL/kg, volume | Finger | 3 respiratory cycl. | Incl. |
| Natalini et al. [ | 2006 | 49 | OR/ICU | Mech. vent. 6–9 mL/kg, volume | Finger/toe | 5 respiratory cycl. | No data |
| Cannesson et al. [ | 2007 | 25 | Preop. CABG/AAA | Mech. vent. 8–10 mL/kg, volume | Finger | 3 respiratory cycl. | Excl. |
| Gen.anaesthesia | |||||||
| Landsverk et al. [ | 2008 | 14 | ICU | Mech. vent. 8 mL/kg, volume/pressure | Finger | 15 min | Incl. |
| Cannesson et al. [ | 2008 | 25 | Preop.CABG | Mech. vent. 8–10 mL/kg | Finger | 3 respiratory cycl. | Excl. |
| Gen.anaesthesia | |||||||
| Pizov et al. [ | 2010 | 33 | Preop. surgery | Mech. vent. 8–10 mL/kg | Finger | 3 min | Incl. |
| Desebbe et al. [ | 2010 | 21 | Postop. CABG and ICU | Mech. vent. 6–10 mL/kg, volume | Finger | 3 respiratory cycl. | Excl. |
| Biais et al. [ | 2011 | 67 | ICU | Mech. vent. 8 mL/kg, volume | Finger | 3 respiratory cycl. | Incl. |
|
| |||||||
| Solus-Biguenet et al. [ | 2006 | 8 | During hepatic surgery | Mech. vent. 8–10 mL/kg | Finger | 3 respiratory cycl. | No data |
| Natalini et al. [ | 2006 | 22 | ICU | Mech. vent. 6–10 mL/kg, volume | Finger | 2 min | No data |
| Cannesson et al. [ | 2007 | 25 | Preop. CABG | Mech. vent. 8–10 mL/kg, volume | Finger | 3 respiratory cycl. | Excl. |
| Feissel et al. [ | 2007 | 23 | ICU | Mech. vent. 8 mL/kg, pressure | Finger | No data | Incl. |
| Wyffels et al. [ | 2007 | 32 | Postop. heart surgery | Mech. vent. 8–10 mL/kg | Finger | 3 respiratory cycl. | No data |
| Cannesson et al. [ | 2008 | 25 | Preop.CABG | Mech. vent. 8–10 mL/kg, volume | Finger | 3 respiratory cycl. | Excl. |
| Gen.anaesthesia | |||||||
| Westphal et al. [ | 2009 | 43 | Postop. heart surgery | Mech. vent. 8–10 mL/kg, volume | Finger | 1 min | Incl. |
| Zimmermann et al. [ | 2010 | 20 | Preop. abd. surgery | Mech. vent. 7 mL/kg, volume | Finger | No data | No data |
| Loupec et al. [ | 2011 | 40 | Several categories | Mech. vent. 8 mL/kg, volume | Finger | No data | Incl. |
| Desgranges et al. [ | 2011 | 28 | Preop. cardiac surgery | Mech. vent. 8 mL/kg, volume | Finger, earlobe | No data | No data |
| and forehead | |||||||
| Renner et al. [ | 2011 | 27 | Infants preop. cardiac surgery | Mech. vent. 10 mL/kg, volume | No data | No data | Excl. |
| Pereira de Souza et al. [ | 2011 | 30 | Children preop neurosurgery | Mech. vent. 10 mL/kg, volume | Finger | 3 respiratory cycl. | Excl. |
| Hoiseth et al. [ | 2011 | 25 | During abd. surgery | Mech. vent. 8 mL/kg, volume | Finger | App. 5 min | Incl. |
| Hood and wilson [ | 2011 | 25 | During colorectal surgery | Mech. vent. 8–10 mL/kg, volume | Finger/earlobe | No data | No data |
ICU: intensive care unit; OR: operating room; CABG: coronary artery bypass grafting; AAA: abdominal aortic aneurysm.